CELL INTELLIGENCE · 肿瘤细胞治疗研究

CAR-T 细胞治疗在儿童、青少年和年轻成人癌症患者中的关键作用

The quintessential role for CAR T cell therapy in children, adolescents and young adults with cancer.

识别与高级别胶质瘤免疫细胞重编程相关的免疫调节性 lncRNA 特征

Identification of an immunomodulatory lncRNA signature associated with immune cell reprogramming in high-grade glioma.

新一代多靶点 CAR 与 STAb-T 免疫治疗：NEXT CAR-T 联盟为克服当前局限的协同努力

Newer generations of multi-target CAR and STAb-T immunotherapeutics: NEXT CART Consortium as a cooperative effort to overcome current limitations.

已上市 CAR-T 细胞（CAR-T 细胞）治疗的实施与运营管理：GoCART Coalition 药师工作组的指南

Implementation and operational management of marketed chimeric antigen receptor T cell (CAR-T Cell) therapy-a guidance by the GoCART Coalition Pharmac

Kymriah®（tisagenlecleucel）：首个获批 CAR-T 疗法临床开发历程概述

Kymriah® (tisagenlecleucel) - An overview of the clinical development journey of the first approved CAR-T therapy.

复发/难治性 B 细胞急性淋巴细胞白血病中自体抗 CD19CAR-T 细胞的长期反应：系统综述和 meta 分析

Long-term response to autologous anti-CD19 chimeric antigen receptor T cells in relapsed or refractory B cell acute lymphoblastic leukemia: a systemat

年轻与年长患者 CAR-T 细胞疗法卫生技术评估的系统综述

A Systematic Review of Health Technology Assessments of Chimeric Antigen Receptor T-Cell Therapies in Young Compared With Older Patients.

与成人相比，年轻患者经模型预测的长期治疗获益可能伴随更大的不确定性，因为细胞和基因治疗可能带来终生获益。